Joined Today: 1

ISPH Inspire Pharmaceuticals, Stock Message Board

All Messages

ISPH Message Board Home | Join The ISPH Group |

#16: ISPH News Inspire Terminates Phase 2 Clinical Trial for Platelet Aggregation Inhibitor
Stock News Bot	August 7, 2006 02:40:00 PM
DURHAM, N.C.--(BUSINESS WIRE)--Aug. 7, 2006--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that it has terminated its Phase 2 clinical trial of INS50589 Antiplatelet, based on the... view message ignore post recommend post

#15: ISPH News Inspire Announces Vice President Appointments
Stock News Bot	August 7, 2006 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Aug. 7, 2006--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today the hiring of two new Vice Presidents, Bart J. Dunn as Vice President, Business Development... view message ignore post recommend post

#14: ISPH News Inspire Announces Webcast of Presentation at Bank of America Specialty Pharmaceuticals Conference
Stock News Bot	August 4, 2006 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Aug. 4, 2006--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Christy L. Shaffer, Ph.D., President and CEO, and Michael R. Knowles, M.D., Professor... view message ignore post recommend post

#13: ISPH News Inspire Initiates Phase 3 Clinical Trial of Denufosol Tetrasodium in Cystic Fibrosis Patients
Stock News Bot	July 27, 2006 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--July 27, 2006--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today the initiation of a Phase 3 clinical trial to evaluate its drug candidate, denufosol... view message ignore post recommend post

#12: ISPH News Inspire Announces Date for Conference Call and Webcast to Discuss Second Quarter 2006 Financial Results
Stock News Bot	July 25, 2006 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--July 25, 2006--Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) announced today that it plans to report second quarter 2006 financial results on Tuesday, August 8, 2006... view message ignore post recommend post

#11: ISPH News Inspire Announces Webcast of Presentation At C.E. Unterberg, Towbin Emerging Growth Conference
Stock News Bot	July 5, 2006 04:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--July 5, 2006--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Thomas R. Staab, II, CFO and Treasurer, will present at the C.E. Unterberg, Towbin... view message ignore post recommend post

#10: ISPH News Inspire Announces Receipt of FDA Approvable Letter for Diquafosol
Stock News Bot	December 2, 2005 01:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Dec. 2, 2005--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that the U.S. Food and Drug Administration (FDA) has issued a second approvable letter for... view message ignore post recommend post

#9: ISPH News Inspire Reports Third Quarter 2005 Financial Results; Third Quarter 2005 Revenue Up 73%, Company Raises 2005 Revenue Guidance
Stock News Bot	November 8, 2005 01:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Nov. 8, 2005--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) today reported financial results for the third quarter ended September 30, 2005. Total revenue for the... view message ignore post recommend post

#8: ISPH News Inspire Announces Date for Conference Call and Webcast to Discuss Third Quarter 2005 Financial Results
Stock News Bot	October 25, 2005 12:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Oct. 25, 2005--Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) today announced that it plans to report third quarter 2005 financial results on Tuesday, November 8, before... view message ignore post recommend post

#7: ISPH News Inspire Provides Update on Cystic Fibrosis Program; Moving Forward to Request End-of-Phase 2 Meeting with FDA
Stock News Bot	October 13, 2005 12:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Oct. 13, 2005--Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) today announced that three studies in its cystic fibrosis (CF) program, including two six-month animal... view message ignore post recommend post

#6: ISPH News Inspire to Present at UBS Global Life Sciences Conference
Stock News Bot	September 21, 2005 12:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Sept. 21, 2005--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Christy L. Shaffer, Ph.D., President and Chief Executive Officer, will present at... view message ignore post recommend post

#5: ISPH News Inspire Announces SEC Investigation
Stock News Bot	September 7, 2005 12:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Sept. 7, 2005--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that the U.S. Securities and Exchange Commission (SEC) is conducting a formal, nonpublic... view message ignore post recommend post

#4: ISPH News Inspire Reports Second Quarter 2005 Financial Results; Second Quarter 2005 Revenue More Than Triple Second Quarter 2004; Company Raises 2005 Guidance
Stock News Bot	August 9, 2005 12:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--Aug. 9, 2005--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) today reported financial results for the second quarter ended June 30, 2005. Total revenue for the second... view message ignore post recommend post

#3: ISPH News Inspire Announces Date for Conference Call and Webcast to Discuss Second Quarter 2005 Financial Results
Stock News Bot	July 26, 2005 12:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--July 26, 2005--Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) today announced that it will report second quarter 2005 financial results on Tuesday, August 9, before the... view message ignore post recommend post

#2: ISPH News Inspire Adds Lynn Smiley, M.D. as Chief Medical Officer
Stock News Bot	July 21, 2005 12:30:00 AM
DURHAM, N.C.--(BUSINESS WIRE)--July 21, 2005--Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) announced today the hiring of M. Lynn Smiley, M.D. for the newly created position of Chief Medical Officer.... view message ignore post recommend post

Group Home | Login if you want to post a message